Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-17T15:14:15.478Z Has data issue: false hasContentIssue false
  • English
  • Français

Indicators of fetal growth and adult liver enzymes: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study

Published online by Cambridge University Press:  06 December 2016

E. W. Harville ,
W. Chen ,
L. Bazzano ,
M. Oikonen ,
N. Hutri-Kähönen  and
O. Raitakari
E. W. Harville*
Affiliation:
Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA
W. Chen
Affiliation:
Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA
L. Bazzano
Affiliation:
Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA
M. Oikonen
Affiliation:
Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Finland
N. Hutri-Kähönen
Affiliation:
Department of Pediatrics, Tampere University Hospital, University of Tampere, Tampere, Finland
O. Raitakari
Affiliation:
Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Finland
*
*Address for correspondence: E. Harville, Associate Professor, Department of Epidemiology, Tulane School of Public Health and Tropical Medicine, Tidewater 2012, 1440 Canal Street, New Orleans, LA 70112, USA. (Email [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Despite the interest in the relationship of fetal exposures to adult cardiovascular disease, few studies have examined indicators of adult fatty liver disease as an outcome. Previous results are inconsistent, and indicate possible variation by sex. Adult liver enzymes [γ-glutamyl transferase (GGT), alanine transaminase (ALT) and aspartase transaminase (AST)] were measured in two cohort studies: the Bogalusa Heart Study (BHS; n=1803) and the Cardiovascular Risk in Young Finns (YF; n=3571) study, which also had ultrasound measures of liver fat (n=2546). Predictors of dichotomized (clinical cut-offs) and continuous (within the reference range) liver enzymes included low birthweight (<2500 g), macrosomia (>4000 g), small-for-gestational-age (birthweight <10th percentile for gestational age for population), large-for-gestational-age (>90th percentile), and preterm birth. Multiple logistic and linear regression were conducted, adjusted for medical, behavioral and socioeconomic indicators. Interactions with sex were also examined. In BHS, birth measures were not strongly associated with clinically high levels of liver enzymes, and within the reference range measures of reduced growth were associated with increased AST in women. In the YF study, at least one marker of reduced growth was associated with higher GGT, higher ALT and higher AST (in women). Probable fatty liver on ultrasound was associated with low birthweight (2.41, 1.42–4.09) and preterm birth (2.84, 1.70–4.76). These results suggest a link between birth parameters and adult fatty liver, but encourage consideration of population variation in these relationships.

Keywords

birthweight-glutamyltransferasegestational agenon-alcoholic fatty liver disease
Type
Original Article
Information
Journal of Developmental Origins of Health and Disease , Volume 8 , Issue 2 , April 2017 , pp. 226 - 235
Check for updates
Copyright
© Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Cottrell, EC, Ozanne, SE. Developmental programming of energy balance and the metabolic syndrome. Proc Nutr Soc. 2007; 66, 198–206.CrossRefGoogle ScholarPubMed
2. Elahi, MM, Cagampang, FR, Mukhtar, D, et al. Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice. Br J Nutr. 2009; 102, 514–519.Google Scholar
3. Sandboge, S, Perala, MM, Salonen, MK, et al. Early growth and non-alcoholic fatty liver disease in adulthood-the NAFLD liver fat score and equation applied on the Helsinki Birth Cohort Study. Ann Med. 2013; 45, 430–437.Google Scholar
4. Fraser, A, Ebrahim, S, Davey Smith, G, Lawlor, DA. The associations between height components (leg and trunk length) and adult levels of liver enzymes. J Epidemiol Community Health. 2008; 62, 48–53.Google Scholar
5. Xia, MF, Yan, HM, Lin, HD, et al. Elevation of liver enzymes within the normal limits and metabolic syndrome. Clin Exp Pharmacol Physiol. 2011; 38, 373–379.Google Scholar
6. Nobili, V, Marcellini, M, Marchesini, G, et al. Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care. 2007; 30, 2638–2640.Google Scholar
7. Anderson, EL, Howe, LD, Fraser, A, et al. Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: the ALSPAC study. J Hepatol. 2014; 61, 626–632.Google Scholar
8. Robertson, T, Benzeval, M. Do mismatches between pre- and post-natal environments influence adult physiological functioning? PLoS One. 2014; 9, e86953.Google Scholar
9. Fraser, A, Ebrahim, S, Ben-Shlomo, Y, Davey Smith, G, Lawlor, DA. Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children: response to Nobili et al. Diabetes Care. 2007;30, e124; author reply e125.Google Scholar
10. Fraser, A, Ebrahim, S, Smith, GD, Lawlor, DA. The associations between birthweight and adult markers of liver damage and function. Paediatr Perinat Epidemiol. 2008; 22, 12–21.Google Scholar
11. Bedogni, G, Bellentani, S, Miglioli, L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006; 6, 33.Google Scholar
12. Sipola-Leppanen, M, Vaarasmaki, M, Tikanmaki, M, et al. Cardiometabolic risk factors in young adults who were born preterm. Am J Epidemiol. 2015; 181, 861–873.CrossRefGoogle ScholarPubMed
13. Breij, LM, Kerkhof, GF, Hokken-Koelega, AC. Risk for Nonalcoholic Fatty Liver Disease in Young Adults Born Preterm. Horm Res Paediatr. 2015; 84, 199–205.Google Scholar
14. Luo, ZC, Xiao, L, Nuyt, AM. Mechanisms of developmental programming of the metabolic syndrome and related disorders. World J Diabetes. 2010; 1, 89–98.CrossRefGoogle ScholarPubMed
15. Simmons, R. Developmental origins of adult metabolic disease: concepts and controversies. Trends Endocrinol Metab. 2005; 16, 390–394.Google Scholar
16. Hales, CN, Barker, DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992; 35, 595–601.CrossRefGoogle ScholarPubMed
17. Raitakari, OT, Juonala, M, Ronnemaa, T, et al. Cohort profile: the Cardiovascular Risk in Young Finns Study. Int J Epidemiol. 2008; 37, 1220–1226.CrossRefGoogle ScholarPubMed
18. Mzayek, F, Hassig, S, Sherwin, R, et al. The association of birth weight with developmental trends in blood pressure from childhood through mid-adulthood: The Bogalusa Heart Study. Am J Epidemiol. 2007; 166, 413–420.Google Scholar
19. Sou, SC, Chen, WJ, Hsieh, WS, Jeng, SF. Severe obstetric complications and birth characteristics in preterm or term delivery were accurately recalled by mothers. J Clin Epidemiol. 2006; 59, 429–435.Google Scholar
20. Jaspers, M, de Meer, G, Verhulst, FC, Ormel, J, Reijneveld, SA. Limited validity of parental recall on pregnancy, birth, and early childhood at child age 10 years. J Clin Epidemiol. 2010; 63, 185–191.Google Scholar
21. Adegboye, AR, Heitmann, B. Accuracy and correlates of maternal recall of birthweight and gestational age. BJOG. 2008; 115, 886–893.Google Scholar
22. Hakim, RB, Tielsch, JM, See, LC. Agreement between maternal interview – and medical record-based gestational age. Am J Epidemiol. 1992; 136, 566–573.Google Scholar
23. Edens, MA, van Ooijen, PM, Post, WJ, et al. Ultrasonography to quantify hepatic fat content: validation by 1H magnetic resonance spectroscopy. Obesity (Silver Spring, Md). 2009; 17, 2239–2244.Google Scholar
24. Saverymuttu, SH, Joseph, AE, Maxwell, JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed). 1986; 292, 13–15.Google Scholar
25. Suomela, E, Oikonen, M, Virtanen, J, et al. Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study. Ann Med. 2015; 47, 40–46.CrossRefGoogle ScholarPubMed
26. Raitakari, OT, Porkka, KV, Taimela, S, et al. Effects of persistent physical activity and inactivity on coronary risk factors in children and young adults. The Cardiovascular Risk in Young Finns Study. Am J Epidemiol. 1994; 140, 195–205.Google Scholar
27. Ceriotti, F, Henny, J, Queralto, J, et al. Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study. Clin Chem Lab Med. 2010; 48, 1593–1601.Google Scholar
28. Patel, DA, Srinivasan, SR, Xu, JH, Chen, W, Berenson, GS. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism. 2007; 56, 792–798.Google Scholar
29. Textor, J, Hardt, J, Knuppel, S. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology. 2011; 22, 745.Google Scholar
30. Ong, KK, Dunger, DB. Perinatal growth failure: the road to obesity, insulin resistance and cardiovascular disease in adults. Best Pract Res Clin Endocrinol Metab. 2002; 16, 191–207.Google Scholar
31. Tu, YK, West, R, Ellison, GT, Gilthorpe, MS. Why evidence for the fetal origins of adult disease might be a statistical artifact: the ‘reversal paradox’ for the relation between birth weight and blood pressure in later life. Am J Epidemiol. 2005; 161, 27–32.CrossRefGoogle ScholarPubMed
32. Yarrington, CD, Cantonwine, DE, Seely, EW, McElrath, TF, Zera, CA. The association of early unexplained elevated alanine aminotransferase with large for gestational age birth weight. Am J Obstet Gynecol. 2016; 215, 474.e1-5.Google Scholar
33. Cai, G, Cole, SA, Haack, K, Butte, NF, Comuzzie, AG. Bivariate linkage confirms genetic contribution to fetal origins of childhood growth and cardiovascular disease risk in Hispanic children. Hum Genet. 2007; 121, 737–744.CrossRefGoogle ScholarPubMed
34. Dasinger, JH, Alexander, BT. Gender differences in developmental programming of cardiovascular diseases. Clin Sci (London). 2016; 130, 337–348.Google Scholar
35. Alexander, BT, Henry Dasinger, J, Intapad, S. Effect of low birth weight on women’s health. Clin Ther. 2014; 36, 1913–1923.Google Scholar
36. Gilbert, JS, Nijland, MJ. Sex differences in the developmental origins of hypertension and cardiorenal disease. Am J Physiol Regul, Integr Comp Physiol. 2008; 295, R1941–R1952.Google Scholar
37. Hagstrom, H, Hoijer, J, Ludvigsson, JF, et al. Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liver Int. 2015; 36, 1688–1695.Google Scholar
38. Aagaard-Tillery, KM, Grove, K, Bishop, J, et al. Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J Mol Endocrinol. 2008; 41, 91–102.Google Scholar
39. McCurdy, CE, Bishop, JM, Williams, SM, et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest. 2009; 119, 323–335.Google Scholar
40. Dudley, KJ, Sloboda, DM, Connor, KL, Beltrand, J, Vickers, MH. Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation. PLoS One. 2011; 6, e21662.Google Scholar
41. Knight, BS, Pennell, CE, Shah, R, Lye, SJ. Strain differences in the impact of dietary restriction on fetal growth and pregnancy in mice. Reprod Sci. 2007; 14, 81–90.Google Scholar
42. Morrison, JL, Duffield, JA, Muhlhausler, BS, Gentili, S, McMillen, IC. Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity. Pediatr Nephrol (Berlin, Germany). 2010; 25, 669–677.Google Scholar
43. Friedman, LS. Approach to the patient with abnormal liver biochemical and function tests, In UpToDate, edited by Chopra S, 2015. UpToDate, Waltham, MA.Google Scholar
44. Goldenberg, RL, Culhane, JF, Iams, JD, Romero, R. Epidemiology and causes of preterm birth. Lancet. 2008; 371, 75–84.Google Scholar
45. Adams, T, Yeh, C, Bennett-Kunzier, N, Kinzler, WL. Long-term maternal morbidity and mortality associated with ischemic placental disease. Semin Perinatol. 2014; 38, 146–150.Google Scholar
Supplementary material: File

Harville supplementary material

Harville supplementary material 1

Download Harville supplementary material(File)
File 184.3 KB
Supplementary material: File

Harville supplementary material

Tables S1-S5

Download Harville supplementary material(File)
File 28.6 KB